1. Understand how the pathophysiology of HRS/AKI in cirrhosis serves as the framework for our clinical approach to this disease.
2. Provide treatment updates for HRS.
3. Look forward towards upcoming diagnostics and therapies for HRS.


Session date: 
12/13/2017 - 4:00pm to 5:00pm CST
UCMC S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Andrew Allegretti, MD, MSc